110 related articles for article (PubMed ID: 19753589)
1. Pleural effusion associated with pegylated interferon alpha and ribavirin treatment for chronic hepatitis C.
Arora A; Vargas L; Kuzniar TJ
J Hosp Med; 2009 Sep; 4(7):E45-6. PubMed ID: 19753589
[TBL] [Abstract][Full Text] [Related]
2. Simultaneous occurrence of pleural effusion and interstitial pneumonitis after treatment with pegylated interferon for hepatitis C virus infection.
Ji F; Li Z; Xue H; Liu L; Deng H
South Med J; 2011 Feb; 104(2):140-2. PubMed ID: 21206334
[TBL] [Abstract][Full Text] [Related]
3. [Sarcoïdose in patient with chronic hepatitis C treated with pegylated interferon].
Moudden MK; Ziadi T; Al Bouzidi A; Ouarssani A; Hadri L; El Baaj M
Rev Pneumol Clin; 2014 Dec; 70(6):362-5. PubMed ID: 25131364
[TBL] [Abstract][Full Text] [Related]
4. [Pegylated-interferon alpha plus ribavirin-induced subacute thyroiditis in chronic hepatitis C].
Abellán Galiana P; Pérez-Lázaro A; Aguilera Sancho-Tello V; Merino Torres JF; Berenguer Haym M; Piñón Sellés F
Endocrinol Nutr; 2009 Mar; 56(3):136-9. PubMed ID: 19627727
[TBL] [Abstract][Full Text] [Related]
5. Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C.
Rogers CJ; Romagosa R; Vincek V
J Am Acad Dermatol; 2004 Apr; 50(4):649-50. PubMed ID: 15034524
[No Abstract] [Full Text] [Related]
6. Development of ocular myasthenia during pegylated interferon and ribavirin treatment for chronic hepatitis C.
Kang HM; Park MJ; Hwang JM; Kim JW; Jeong SH
Korean J Hepatol; 2009 Jun; 15(2):209-15. PubMed ID: 19581773
[TBL] [Abstract][Full Text] [Related]
7. Interstitial pneumonitis after combination therapy with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
Chen YC; Lu SN; Lin MC
Chang Gung Med J; 2007; 30(1):92-7. PubMed ID: 17477035
[TBL] [Abstract][Full Text] [Related]
8. Dual onset of type 1 diabetes mellitus and Graves' disease during treatment with pegylated interferon alpha-2b and ribavirin for chronic hepatitis C.
Hayashi M; Kataoka Y; Tachikawa K; Koguchi H; Tanaka H
Diabetes Res Clin Pract; 2009 Nov; 86(2):e19-21. PubMed ID: 19744739
[TBL] [Abstract][Full Text] [Related]
9. [Pulmonary toxicity by pegylated interferon alpha-2a in a patient with chronic hepatitis C].
Son BK; Sohn JH; Kim TY; Park YK; Jeon YC; Han DS
Korean J Hepatol; 2007 Mar; 13(1):103-7. PubMed ID: 17380081
[TBL] [Abstract][Full Text] [Related]
10. Alopecia universalis: a rare side effect seen on chronic hepatitis C treatment with peg-IFN and ribavirin.
Demirturk N; Aykin N; Demirdal T; Cevik F
Eur J Dermatol; 2006; 16(5):579-80. PubMed ID: 17101483
[No Abstract] [Full Text] [Related]
11. Interstitial pneumonitis after treatment for hepatitis C virus infection.
Botnaru V; Munteanu O; Rusu D
Pneumologia; 2015; 64(1):46-50. PubMed ID: 26016056
[TBL] [Abstract][Full Text] [Related]
12. Exacerbation of oral lichen planus lesions during treatment of chronic hepatitis C with pegylated interferon and ribavirin.
Grossmann Sde M; Teixeira R; de Aguiar MC; do Carmo MA
Eur J Gastroenterol Hepatol; 2008 Jul; 20(7):702-6. PubMed ID: 18679075
[TBL] [Abstract][Full Text] [Related]
13. Interstitial pneumonitis associated with pegylated interferon alpha-2b therapy for chronic hepatitis C: case report.
Carrillo-Esper R; González-Avila D; Uribe-Ríos M; Méndez-Sánchez N
Ann Hepatol; 2008; 7(1):87-90. PubMed ID: 18376374
[TBL] [Abstract][Full Text] [Related]
14. Occurrence of diffuse, poorly differentiated hepatocellular carcinoma during pegylated interferon plus ribavirin combination therapy for chronic hepatitis C.
Capanni M; Lorefice E; Benini MC; Biagini MR; Tozzi A; Salvadori E; Colagrande S; Surrenti C; Milani S
J Chemother; 2008 Jun; 20(3):380-4. PubMed ID: 18606596
[TBL] [Abstract][Full Text] [Related]
15. Interstitial pneumonia recurrence during chronic hepatitis C treatment.
Renou C; Germain S; Harafa A; Martin S; Larroque O; Muller P; Bertrand JJ; Halfon P
Am J Gastroenterol; 2005 Jul; 100(7):1625-6. PubMed ID: 15984999
[No Abstract] [Full Text] [Related]
16. Combination pegylated interferon and ribavirin therapy precipitating acute renal failure and exacerbating IgA nephropathy.
Gordon A; Menahem S; Mitchell J; Jenkins P; Dowling J; Roberts SK
Nephrol Dial Transplant; 2004 Aug; 19(8):2155. PubMed ID: 15252182
[No Abstract] [Full Text] [Related]
17. Pyoderma gangrenosum and exacerbation of psoriasis resulting from pegylated interferon alpha and ribavirin treatment of chronic hepatitis C.
Yurci A; Guven K; Torun E; Gursoy S; Baskol M; Akgun H; Ozbakir O; Yucesoy M
Eur J Gastroenterol Hepatol; 2007 Sep; 19(9):811-5. PubMed ID: 17700270
[TBL] [Abstract][Full Text] [Related]
18. [A case of sudden-onset hearing loss in a patient treated with peginterferon alpha-2b and ribavirin for chronic hepatitis C].
Shin MK; Kim TH; Ju K; Ha CY; Min HJ; Jung WT; Lee OJ
Korean J Hepatol; 2009 Sep; 15(3):370-4. PubMed ID: 19783887
[TBL] [Abstract][Full Text] [Related]
19. Erythema annulare centrifugum due to pegylated interferon-α-2a plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection.
Gönül M; Külcü Çakmak S; Ozcan N; Deniz Oǧuz I; Ozhamam E
J Cutan Med Surg; 2014; 18(1):65-8. PubMed ID: 24377478
[TBL] [Abstract][Full Text] [Related]
20. [A case of Bell's palsy associated with peginterferon Alfa-2a and ribavirin therapy for chronic hepatitis C virus infection].
Lee MY; Cho H; Kim YM; Lee JS
Korean J Hepatol; 2006 Sep; 12(3):444-8. PubMed ID: 16998297
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
